19.67 USD
↗ 0.46 (2.40%)AT CLOSE (11:59 AM EDT)
Dyne Therapeutics, Inc. Common Stock
DYNNASDAQ • USD
19.69
↗ 0.02 (0.10%)
POST MARKET (AS OF 07:15 PM EDT)
Post Market
AS OF 07:15 PM EDT
19.69
↗ 0.02 (0.10%)
Market: CLOSED
Open?$19.25
High?$20.03
Low?$19.04
Prev. Close?$19.21
Volume?2.1M
Avg. Volume?2.3M
VWAP?$19.64
Rel. Volume?0.95x
Bid / Ask
Bid?$17.13 × 100
Ask?$22.63 × 100
Spread?$5.50
Midpoint?$19.88
Valuation & Ratios
Market Cap?3.2B
Shares Out?165.2M
Float?128.9M
Float %?90.2%
P/E Ratio?N/A
P/B Ratio?3.26
EPS?-$2.70
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?22.25Strong
Quick Ratio?22.25Strong
Cash Ratio?17.65Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?3.26FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-45.9%WEAK▾
ROA?-37.6%WEAK▾
Cash Flow & Enterprise
FCF?$-423917000
Enterprise Value?$2.4B
News
Profile
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Address
1560 TRAPELO ROAD
WALTHAM, MA 02451
Phone: (781) 786-8230
WALTHAM, MA 02451
Phone: (781) 786-8230